据证券之星公开数据整理，近期云南白药（000538）发布2025年中报。截至本报告期末，公司营业总收 入212.57亿元，同比上升3.92%，归母净利润36.33亿元，同比上升13.93%。按单季度数据看，第二季度 营业总收入104.16亿元，同比上升7.59%，第二季度归母净利润16.98亿元，同比上升14.22%。本报告期 云南白药盈利能力上升，毛利率同比增幅5.33%，净利率同比增幅9.94%。 本次财报公布的各项数据指标表现尚佳。其中，毛利率30.86%，同比增5.33%，净利率17.15%，同比增 9.94%，销售费用、管理费用、财务费用总计28.57亿元，三费占营收比13.44%，同比增10.2%，每股净 资产22.65元，同比增2.63%，每股经营性现金流2.22元，同比增21.45%，每股收益2.04元，同比增 13.97% 偿债能力：公司现金资产非常健康。 | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 204.55 Z | 212.57 乙 | 3.92% | | 归母净利润(元) | 31. ...

Core Viewpoint - Yunnan Baiyao, a leading company in the traditional Chinese medicine industry, reported strong financial performance for the first half of 2025, achieving record high net profit and revenue growth [1][2]. Financial Performance - The company achieved operating revenue of 21.26 billion yuan, a year-on-year increase of 3.92% [2]. - The net profit attributable to shareholders reached 3.63 billion yuan, up 13.93% year-on-year, marking a historical high for the period [1][2]. - The net profit after deducting non-recurring gains and losses was 3.46 billion yuan, reflecting a 10.40% increase year-on-year [2]. - The net cash flow from operating activities was 3.96 billion yuan, a significant increase of 21.45% [2]. - Basic and diluted earnings per share were both 2.04 yuan, representing a 13.97% increase [2]. - The weighted average return on equity rose to 9.09%, an increase of 1.16 percentage points year-on-year [2]. Dividend Announcement - The company announced a special dividend plan, proposing to distribute 10.19 yuan per 10 shares (including tax), totaling approximately 1.82 billion yuan, which accounts for 50.05% of the net profit for the first half of 2025 [1][2]. Product Performance - The core product, aerosol spray, generated over 1.45 billion yuan in revenue, with a significant year-on-year growth of over 20.9% [4][5]. - The pharmaceutical business segment reported revenue of 4.75 billion yuan, a 10.8% increase year-on-year [5]. - The health products segment achieved revenue of 3.44 billion yuan, reflecting a 9.46% growth [6]. - The commercial segment, Yunnan Provincial Pharmaceutical Co., Ltd., reported a revenue of 12.16 billion yuan, with a net profit of 351 million yuan, up 17.75% [6]. Industry Development - The Yunnan provincial government emphasizes the development of the traditional Chinese medicine industry, positioning it as a key focus for the province's agricultural economy [6]. - The company is committed to building an industrial cluster centered around itself, promoting collaboration across the supply chain [6]. Innovation Strategy - The company adheres to an innovation-driven development strategy, focusing on both traditional Chinese medicine and innovative pharmaceuticals [8]. - It aims to enhance its research and development capabilities for traditional Chinese medicine while also exploring innovative drug development [8]. - The national "14th Five-Year Plan" includes support for the biopharmaceutical industry, presenting new opportunities for the healthcare sector [8].

登录新浪财经APP 搜索【信披】查看更多考评等级 是否以公积金转增股本 □是 √否 证券代码：000538 证券简称：云南白药公告编号：2025-28 一、重要提示 本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投 资者应当到证监会指定媒体仔细阅读半年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 √适用 □不适用 公司经本次董事会审议通过的利润分配预案为：以1,784,262,603股为基数，向全体股东每10股派发现金 红利10.19元（含税），送红股0股（含税），不以公积金转增股本。 董事会决议通过的本报告期优先股利润分配预案 □适用 √不适用 二、公司基本情况 1、公司简介 ■ 2、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ 3、公司股东数量及持股情况 单位：股 ■ 持股5%以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况 □适用 √不适用 前10名股东及前10名无限售流通股股东因转融通出借/归还原因 ...

Mergers and Acquisitions - Jia Yuan Technology plans to invest 500 million yuan to acquire a stake in Wuhan Endatong Technology Co., Ltd, with 150 million yuan for share transfer and 350 million yuan for capital increase, resulting in a 13.587% ownership stake [1] - SMIC is planning to issue A-shares to purchase minority stakes in its subsidiary, SMIC North, with stock suspension expected for no more than 10 trading days starting September 1, 2025 [2] - Aier Eye Hospital intends to acquire partial stakes in three medical institutions for 105 million yuan to enhance its "graded chain" development model [3] Performance Disclosure - China Railway reported a 5.93% decline in revenue to 511.09 billion yuan and a 17.17% decrease in net profit to 11.83 billion yuan for the first half of 2025 [4] - China Rare Earth achieved a net profit of 162 million yuan, reversing a loss of 244 million yuan from the previous year, with a 62.38% increase in revenue to 1.875 billion yuan [5] - Yunnan Baiyao's revenue grew by 3.92% to 21.257 billion yuan, with a net profit increase of 13.93% to 3.633 billion yuan [6] - China Shipbuilding reported a 11.96% increase in revenue to 40.325 billion yuan and a 108.59% rise in net profit to 2.946 billion yuan [7] - BeiGene turned a net loss of 2.88 billion yuan from the previous year into a profit of 450 million yuan, with a 46.03% increase in revenue to 17.52 billion yuan [8] Shareholding Changes - Kweichow Moutai's controlling shareholder plans to increase its stake by 3 to 3.3 billion yuan within six months, based on confidence in the company's long-term value [9] - Huasheng Tiancheng's director and supervisor plan to reduce their holdings by a total of up to 1% due to personal financial needs [10] - Zhejiang Wen Film's shareholder plans to reduce holdings by up to 0.43% for personal financial needs [11] - Chenxin Pharmaceutical's major shareholder plans to reduce holdings by up to 1% for funding requirements [12] Investment Activities - Yinglian Co. plans to invest 918 million yuan in a can lid manufacturing project, expected to generate over 2.158 billion yuan in annual revenue [13] - Zhiyang Innovation intends to invest 20 million yuan to establish a wholly-owned subsidiary to promote embodied intelligence technology innovation [14]

Company Announcements - SMIC plans to issue A-shares to acquire minority stakes in its subsidiary, SMIC North, leading to a temporary suspension of its stock trading for up to 10 trading days [1] - Huasheng Tiancheng's director and supervisor plan to reduce their holdings by up to 0.9984% of the total shares [2] - BYD reported a net profit of 15.51 billion yuan for the first half of the year, a year-on-year increase of 13.79% [2] - Changfei Fiber's net profit for the first half of the year was 296 million yuan, down 21.71% year-on-year [2] - Jia Yuan Technology plans to invest 500 million yuan to acquire part of the equity in Endatong, focusing on the optical module industry [1][17] - Guizhou Moutai completed the repurchase of 3.9276 million shares [1][19] Financial Performance - CEC reported a net profit of 24.641 billion yuan for the first half of the year, a decrease of 12% year-on-year [5] - Longjiang Power achieved a net profit of 13.056 billion yuan, up 14.86% year-on-year [8] - China Rare Earth reported a net profit of 162 million yuan, turning from a loss of 244 million yuan in the previous year [9] - Huayi Brothers' net profit increased by 48.34% to 2.028 billion yuan [6] - Wealth Trend's net profit grew by 6.61% year-on-year [24] Mergers and Acquisitions - Tailin Micro plans to acquire 100% of Panqi Micro's equity through a combination of cash and stock issuance [4] - Aishen Medical announced the acquisition of partial equity in three medical institutions for a total of 105 million yuan [18] Stock Movements - Guizhou Moutai's controlling shareholder plans to increase its stake by 3 to 3.3 billion yuan [15] - Ganfeng Lithium plans to invest 4 billion yuan to build a new lithium-ion battery manufacturing base [16] Market Developments - China National Offshore Oil Corporation won a bid for a project in Qatar worth approximately 4 billion USD [14] - Aishen Medical's acquisition of equity in medical institutions aims to enhance its service coverage and operational efficiency [18]

Growth - Huayin Power reported a net profit of 207 million yuan for the first half of the year, a year-on-year increase of 4146.80% [1] - Guotou Zhonglu achieved a net profit of 25.08 million yuan, up 2149.03% year-on-year [1] - Jianfeng Group's net profit reached 618 million yuan, reflecting a year-on-year growth of 1196.93% [1] - Haixiang New Materials reported a net profit of 64.95 million yuan, with a year-on-year increase of 1099.05% [1] - Shanshan Co. posted a net profit of 207 million yuan, up 1079.59% year-on-year [1] - Huaxia Airlines achieved a net profit of 251 million yuan, a year-on-year increase of 858.95% [1] - Haitan Ruisheng reported a net profit of 3.80 million yuan, reflecting a year-on-year growth of 813.65% [1] - Wentai Technology's net profit was 474 million yuan, up 237.36% year-on-year [1] - ST Yigou reported a net profit of 48.69 million yuan, a year-on-year increase of 230.03% [1] - Youyan New Materials achieved a net profit of 130 million yuan, reflecting a year-on-year growth of 218.47% [1] - Guotai Haitong reported a net profit of 15.737 billion yuan, up 213.74% year-on-year [1] - Batian Co. posted a net profit of 456 million yuan, reflecting a year-on-year increase of 203.71% [1] - Changjiang Securities achieved a net profit of 1.737 billion yuan, up 120.76% year-on-year [1] - China Shipbuilding reported a net profit of 2.946 billion yuan, reflecting a year-on-year growth of 108.59% [1] - Shenwan Hongyuan posted a net profit of 4.284 billion yuan, up 101.32% year-on-year [1] - Zhongwei Semiconductor reported a net profit of 86.47 million yuan, reflecting a year-on-year increase of 100.99% [1] - Lankai Technology achieved a net profit of 1.159 billion yuan, up 95.41% year-on-year [1] - CICC reported a net profit of 4.33 billion yuan, reflecting a year-on-year growth of 94.35% [1] - TCL Technology posted a net profit of 1.883 billion yuan, up 89.26% year-on-year [1] - Guoxin Securities achieved a net profit of 5.367 billion yuan, reflecting a year-on-year increase of 71% [1] - Haowei Group reported a net profit of 2.028 billion yuan, up 48.34% year-on-year [1] - GF Securities posted a net profit of 6.47 billion yuan, reflecting a year-on-year growth of 48.31% [1] - Huatai Securities achieved a net profit of 7.549 billion yuan, up 42.16% year-on-year [1] - Lingyi Manufacturing reported a net profit of 930 million yuan, reflecting a year-on-year increase of 35.94% [1] - Guoxuan High-Tech achieved a net profit of 367 million yuan, up 35.22% year-on-year [1] - Zoomlion reported a net profit of 2.765 billion yuan, reflecting a year-on-year growth of 20.84% [1] - Yunnan Baiyao posted a net profit of 3.633 billion yuan, up 13.93% year-on-year [1] - BYD achieved a net profit of 15.511 billion yuan, reflecting a year-on-year increase of 13.79% [1] Decline and Loss - Agricultural Bank reported a net profit of 139.51 billion yuan, a year-on-year increase of 2.7% [2] - Gujing Gongjiu achieved a net profit of 3.662 billion yuan, up 2.49% year-on-year [2] - Bank of Communications reported a net profit of 46.016 billion yuan, reflecting a year-on-year increase of 1.61% [2] - Postal Savings Bank achieved a net profit of 49.228 billion yuan, up 0.85% year-on-year [2] - China Rare Earth reported a net profit of 16.2 million yuan, turning from loss to profit [2] - New Hope achieved a net profit of 75.5 million yuan, turning from loss to profit [2] - BeiGene reported a net profit of 450 million yuan, turning from loss to profit [2] - Shenghe Resources achieved a net profit of 37.7 million yuan, turning from loss to profit [2] - China Great Wall reported a net profit of 13.8 million yuan, turning from loss to profit [2] - Tianqi Lithium reported a net profit of 8.441 million yuan, turning from loss to profit [2] - Yunda Holdings reported a net profit of 52.9 million yuan, a year-on-year decline of 49.19% [2] - Magmi Te reported a net profit of 17.4 million yuan, down 44.82% year-on-year [2] - Youa Holdings reported a net profit of 5.348 million yuan, down 45.61% year-on-year [2] - Yanzhou Coal reported a net profit of 4.652 billion yuan, down 38.53% year-on-year [2] - Changfei Optical Fiber reported a net profit of 296 million yuan, down 21.71% year-on-year [2] - Pianzaihuang reported a net profit of 1.442 billion yuan, down 16.22% year-on-year [2] - China Shenhua reported a net profit of 246.41 billion yuan, down 12% year-on-year [2] - China Railway reported a net profit of 118.27 billion yuan, down 17.17% year-on-year [2] - Luzhou Laojiao reported a net profit of 766.3 million yuan, down 4.54% year-on-year [2] - Industrial and Commercial Bank reported a net profit of 168.103 billion yuan, down 1.4% year-on-year [2] - China Construction Bank reported a net profit of 162.076 billion yuan, down 1.37% year-on-year [2] - Jingwang Electronics reported a net profit of 64.9 million yuan, down 1.06% year-on-year [2] - Bank of China reported a net profit of 117.591 billion yuan, down 0.85% year-on-year [2] - Beijing-Shanghai High-Speed Railway reported a net profit of 6.316 billion yuan, down 0.64% year-on-year [2] - Baike Biotechnology reported a net loss of 73.5734 million yuan, turning from profit to loss [2] - ST Xintong reported a net loss of 95.1607 million yuan, turning from profit to loss [2] - Gemdale Group reported a net loss of 3.701 billion yuan [2] - China Eastern Airlines reported a net loss of 1.431 billion yuan [2] Additional Losses - Garden Holdings reported a net loss of 74.4346 million yuan [3] - Wantong Development reported a net loss of 28.0411 million yuan [3]

智通财经APP讯，云南白药(000538.SZ)发布2025年半年度报告，报告期内，公司实现营业收入212.57亿 元，同比增长3.92%。实现归属于上市公司股东的净利润36.33亿元，同比增长13.93%。实现归属于上市 公司股东的扣除非经常性损益的净利润34.61亿元，同比增长10.40%。基本每股收益2.04元。 ...

Core Viewpoint - Yunnan Baiyao reported record high performance for the first half of 2025, with a net profit growth of double digits, and announced a special dividend plan [1] Financial Performance - Revenue for the first half of 2025 reached 21.257 billion yuan, a year-on-year increase of 3.92% [1] - Net profit attributable to shareholders was 3.633 billion yuan, up 13.93% year-on-year, marking a historical high for the period [1] - Non-recurring net profit was 3.461 billion yuan, a 10.40% increase year-on-year [1] - Basic earnings per share were 2.04 yuan, reflecting a 13.97% growth [1] - Operating cash flow net amount was 3.961 billion yuan, up 21.45% year-on-year [1] Business Strategy and Development - The company has implemented a new model for party building, enhancing cohesion and competitiveness, which supports high-quality development [2] - Yunnan Baiyao is focusing on optimizing resource allocation and improving management capabilities as part of its strategic planning for 2024-2028 [2] Industrial and Product Performance - The industrial segment's revenue accounted for 40.01% of total revenue, with an increase of 2.6 percentage points year-on-year, and an industrial revenue growth rate of 11.13% [3] - The pharmaceutical sector achieved a revenue of 4.751 billion yuan, growing by 10.8% year-on-year, with significant sales increases in various product lines [3] - The health products segment generated 3.442 billion yuan in revenue, a 9.46% increase, maintaining a leading market share in toothpaste [4] - The commercial segment reported a revenue of 12.164 billion yuan, with a net profit of 351 million yuan, reflecting a 17.75% increase [5] Innovation and R&D - Yunnan Baiyao is advancing its R&D efforts with a focus on both traditional Chinese medicine and innovative drugs, with several projects in various stages of clinical trials [8] - The company has adopted a precise R&D and transformation model for its seed industry, achieving significant growth in the number of shipments despite market price pressures [7] Digital Transformation - The company is enhancing its digital transformation through AI and data technologies, achieving over 1 billion yuan in online business transactions [10] - A fully automated settlement process has been established, significantly reducing paper usage and improving operational efficiency [10] Future Outlook - Yunnan Baiyao aims to leverage strategic mergers and acquisitions to achieve sustainable growth and enhance investor returns, aligning with national policies to improve the quality of traditional Chinese medicine [11]

证券日报网讯8月29日晚间，云南白药（000538）发布公告称，公司将于2025年9月15日召开2025年第一 次临时股东大会。本次股东大会将审议《关于2025年特别分红方案的议案》等多项议案。 ...

北京商报讯（记者丁宁）8月29日晚间，云南白药（000538）发布2025年半年报显示，公司上半年实现 营业收入212.57亿元，同比增长3.92%；归属净利润36.33亿元，同比增长13.93%。 同时，云南白药发布2025年特别分红方案显示，拟向全体股东每10股派发现金红利10.19元（含税）。 （文章来源：北京商报） ...